Healthcare - Press Releases

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The globalhome fitness equipment market size is estimated to grow by USD 4.44 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.38% during the forecast period. Increased demand for home fitness equipment is driving market growth, with a trend towards increasing smartphone penetration. However, rising popularity of other forms of workouts poses a challenge. Key market players includeANTA Sports Products Ltd., Core Health and Fitness LLC, Decathlon SA, Dyaco International Inc., HOIST Fitness Systems Inc., Icon Health and Fitness Inc., Impulse Qingdao Health Tech Co. Ltd., Johnson Health Tech Co. Ltd., Life Fitness, Nautilus Inc., Origin Fitness Ltd., Paradigm Health and Wellness Inc., Rama Enterprises, TECHNOGYM S.p.A, Torque Fitness, True Fitness Technology Inc., Tunturi New Fitness BV, Wattbike Ltd., WOODWAY Inc., and XMark Fitness.

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The globalwearable technology market size is estimated to grow by USD 99.4 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over17.3% during the forecast period. Popularity of wearable devices as a payment methodis driving market growth,with a trend towardsdevelopment of low-power electronics. However,rising penetration of counterfeit products poses a challenge. Key market players include Apple Inc., ASUSTeK Computer Inc., BAE Systems Plc, CINOPTICS, Citizen Watch Co. Ltd., Elbit Systems Ltd., Garmin Ltd., Google LLC, Huawei Technologies Co. Ltd., Kopin Corp., Lenovo Group Ltd., LG Corp., Magic Leap Inc., Misfit Inc., Polar Electro Oy, Samsung Electronics Co. Ltd., Sony Semiconductor Israel Ltd., Tex Ray Industrial Co. Ltd., Vuzix Corp., and Xiaomi Inc..

NEW YORK, Feb. 12, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The globalginseng market size is estimated to grow by USD 195.03 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.05% during the forecast period. Rising awareness of health benefits of ginsengis driving market growth,with a trend towardsincreased demand for organic ginseng products. However,high susceptibility of ginseng plants to pests and diseases poses a challenge. Key market players include AOS Products Pvt. Ltd., Auragin LLC, Bio Botanica Inc., Botalys SA, Herbal Creations, KAVYA PHARMA, Korea Ginseng Corp., MotherTree Nutra Pvt. Ltd., Natures Way Brands LLC, Nestle SA, Uniray Life Sciences, Velnex Medicare, Zoic Pharmaceuticals Pvt. Ltd., Bob Ginseng LLC, Canada Royal Enoch Phytomedicine Ltd., Ethical Naturals Inc., FREDERIC M, and G and G Century M Sdn Bhd.

OSLO, Norway, Feb. 12, 2025 /PRNewswire/ -- For the full year 2024,Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, delivered revenues of NOK 531.3, which is 3.8 per cent up from 2023. Adjusted EBITDA amounted to NOK 46.6 million, compared to NOK 51.5 million last year. Gross margin ended at 39.3 per cent, up from 38.9 per cent in 2023.

RICHMOND, Va., Feb. 12, 2025 /PRNewswire/ --Indivior PLC (Nasdaq/LSE: INDV)provides the following update regarding its PDUFA action date for label changes (rapid initiation protocol and alternative injection sites) for SUBLOCADE (buprenorphine extended-release) Injection, which was scheduled for February 7, 2025:

VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop for the treatment of acid reflux, a treatment field with 1 billion sufferers, is pleased to announce that the FDA has accepted Module 1 of the company's premarket approval (PMA) application, and that this module is now considered closed.

The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.

Das Unternehmen gibt dieCE MDR-Zulassung fr sein neuartiges Neurodiagnose-Medizinprodukt Delphi-MD bekannt und bereitet sich damit auf die Vermarktung in der EU vor.

La socit annonce l'approbation CEMDR pour son nouveau dispositif mdical de neurodiagnostic Delphi-MD en vue de sa commercialisation dans l'UE, amliorant ainsi les rsultats cliniques et le bien-tre des patients tout en rduisant la charge financire des systmes de soins de sant et des payeurs.

The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.

STOCKHOLM, Feb. 12, 2025 /PRNewswire/ -- The Board of Directors of Medicover AB (publ) ("Medicover") today announces that John Stubbington will succeed Fredrik Rgmark as new CEO of the Medicover group from 1 May 2025.

STOCKHOLM, Feb. 12, 2025 /PRNewswire/ -- Fourth quarter

- Ajinomoto Co., Inc., a travs de su subsidiaria Ajinomoto Health & Nutrition North America, Inc., anuncia el patrocinio de oro de LabCentral: Acelerando la innovacin en biotecnologa

SANDNES, Norway, Feb. 12, 2025 /PRNewswire/ -- Desert Control AS (DSRT) announces its fourth quarter report and interim full-year financial results for the fiscal period ending 31 December 2024.

PARS, 11 de febrero de 2025 /PRNewswire/ -- El Congreso Mundial IMCAS 2025, el mayor congreso cientfico de esttica del mundo, se celebr a lo grande en Pars del 30 de enero al 1 de febrero, celebrando su 26 aniversario.

SALT LAKE CITY, Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its underwritten public offering of 1,250,000 shares of its Class A common stock at a public offering price of $4.00 per share, and, in lieu of Class A common stock to certain investors, pre-funded warrants to purchase 11,250,000 shares of its Class A common stock at a public offering price of $3.9999 per pre-funded warrant, which equals the public offering price per share of the Class A common stock less the $0.0001 per share exercise price of each pre-funded warrant, in each case before underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sera, are expected to be approximately $50 million. Sera has granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The pre-funded warrants will be immediately exercisable, and may be exercised at any time after their original issuance. All of the shares and pre-funded warrants are being offered by Sera. The offering is expected to close on February 12, 2025, subject to the satisfaction of customary closing conditions.

PARIS, 11. Februar 2025 /PRNewswire/ -- Der IMCAS-Weltkongress 2025, der weltweit grte wissenschaftliche sthetikkongress, fand vom 30. Januar bis 1. Februar in Paris statt und feierte damit sein 26-jhriges Bestehen.

PARIS, 11 fvrier 2025 /PRNewswire/ -- Le congrs mondial 2025 de l'IMCAS, le plus grand congrs scientifique d'esthtique au monde, s'est tenu avec faste Paris du 30 janvier au 1er fvrier, clbrant ainsi son 26e anniversaire.

DUBAI, UAE, Feb. 11, 2025 /PRNewswire/ -- The future of healthcare guidance is here. The revolutionaryXRPH AI App, built to evolve and continually learn, has officially launched and is available for free download on Google Play, the App Store, and directly via XRPH.ai.

LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025. This expansion marks the latest step in Bio X Cell's growing international presence, complementing its flagship distribution center in Germany, as well as partnerships that extend the Bio X Cell name to Singapore and Korea, along with its headquarters and manufacturing facility in New Hampshire.

LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025. This expansion marks the latest step in Bio X Cell's growing international presence, complementing its flagship distribution center in Germany, as well as partnerships that extend the Bio X Cell name to Singapore and Korea, along with its headquarters and manufacturing facility in New Hampshire.

ABU DHABI, UAE, Feb. 11, 2025 /PRNewswire/ -- PureHealth Holding PJSC ("PureHealth" or "the Group") (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the period ended 31 December 2024. The Group recorded a strong revenue increase of 58% year-on-year to AED 25.8 billion in FY-2024, driven by robust growth across its core segments, including Hospitals, Insurance and Procurement; and was further strengthened by the successful integration of strategic acquisitions. The Group's strong performance reflected positively on profitability, with EBITDA growing 69% year-on-year to AED 4.1 billion and net profit increasing by 78% year-on-year to AED 1.7 billion in FY-2024.

NEW YORK, Feb. 11, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global wearable technology marketsize is estimated to grow by USD 99.4 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over17.3% during the forecast period. Popularity of wearable devices as a payment methodis driving market growth,with a trend towardsdevelopment of low-power electronics. However,rising penetration of counterfeit products poses a challenge. Key market players include Apple Inc., ASUSTeK Computer Inc., BAE Systems Plc, CINOPTICS, Citizen Watch Co. Ltd., Elbit Systems Ltd., Garmin Ltd., Google LLC, Huawei Technologies Co. Ltd., Kopin Corp., Lenovo Group Ltd., LG Corp., Magic Leap Inc., Misfit Inc., Polar Electro Oy, Samsung Electronics Co. Ltd., Sony Semiconductor Israel Ltd., Tex Ray Industrial Co. Ltd., Vuzix Corp., and Xiaomi Inc..

LINKPING, Sweden, Feb. 11, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) announces that Region Vstra Gtaland, Sweden's second largest healthcare region, will use Sectra's digital pathology solution. This marks an expansion of a more than 20-year collaboration for medical imaging between the healthcare provider and Sectra. The digital pathology solution will enable the hospitals, that also use Sectra for radiology, to efficiently carry out the entire imaging diagnostic process within a single application, while also providing tools for enhanced collaboration. This will contribute to improved diagnostic accuracy and speed of treatment, with the goal of improving especially cancer care in the region.

YONGIN, South Korea, Feb. 11, 2025 /PRNewswire/ --GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, held from Feb. 3rd to 7th, 2025, in San Diego, USA.